Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours

This publication has 25 references indexed in Scilit:

• Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
  Seminars in Nuclear Medicine, 2002
• Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies
  Seminars in Nuclear Medicine, 2002
• ⁹⁰Y–DOTA–D‐Phe¹–Try³– octreotide in therapy of neuroendocrine malignancies
  Peptide Science, 2002
• Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
  Journal of Clinical Endocrinology & Metabolism, 2001
• All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl Cyclase
  Biochemical and Biophysical Research Communications, 1994
• Somatostatin Receptor Scintigraphy of Carcinoid Tumours Using the [¹¹¹In-Dtpa-D-Phe¹]-Octreotide
  Acta Oncologica, 1993
• Positron Emission Tomography (PET) in Neuroendocrine Gastrointestinal Tumors
  Acta Oncologica, 1993
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• THE CYTOCHEMISTRY AND ULTRASTRUCTURE OF POLYPEPTIDE HORMONE-PRODUCING CELLS OF THE APUD SERIES AND THE EMBRYOLOGIC, PHYSIOLOGIC AND PATHOLOGIC IMPLICATIONS OF THE CONCEPT
  Journal of Histochemistry & Cytochemistry, 1969
• Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin
  Proceedings of the Royal Society of London. B. Biological Sciences, 1968